AVP and depressive disorder: Additional findings in animal models also demonstrate cross-talk between vasopressin and serotonin systems at the behavioral level, with V1b receptor antagonism achieving anti-depressant-like effects [57] and SSRI rescue of depression-like phenotypes acting in an AVP-dependent fashion [26, 58].